The US has exempted certain specialty pharmaceutical products and related ingredients from tariffs for India and 19 other jurisdictions. The zero-tariff treatment covers specified medicines for rare diseases, fertility treatments, cell and gene therapies and other specialty products. The exemption comes as the US begins imposing 100% tariffs on certain patented pharmaceutical imports from September 29.